Microtek Medical Holdings Announces Acceleration of Option Vesting
December 21 2005 - 5:00PM
PR Newswire (US)
ALPHARETTA, Ga., Dec. 21 /PRNewswire-FirstCall/ -- Microtek Medical
Holdings, Inc. (NASDAQ:MTMD), a leading manufacturer and supplier
of innovative product solutions for patient care, occupational
safety and management of infectious and hazardous waste for the
healthcare industry, today announced that, on December 20, 2005,
the Company's Board of Directors approved accelerating the vesting
of all unvested stock options previously awarded to its employees.
As a result of this action, options to purchase approximately
950,000 shares of the Company's common stock at exercise prices
ranging from $1.90 to $4.72 per share and at a weighted average
exercise price of $3.96 became exercisable immediately. Without the
acceleration, the options would otherwise vest over the next one to
four years. Included in the options accelerated by this action were
35,000 options held by one of the Company's executive officers,
namely its Chief Operating Officer. None of the Company's other
executive officers or its non-employee directors were affected by
this action. The exercise prices and number of shares subject to
the accelerated options remain unchanged. The decision to
accelerate the vesting of these stock options was made to eliminate
future non-cash compensation expense that would otherwise be
recorded in its statement of operations in future periods upon
adoption of Statement of Financial Accounting Standard No. 123R,
"Share-Based Payment" ("SFAS No. 123R") on January 1, 2006. Upon
adoption, SFAS No. 123R will require all future share-based
payments to employees, officers and directors, including grants of
employee stock options, to be recognized as compensation expense in
the Company's financial statements at the grant date. The Company
will report the accelerated future compensation expense in its
Annual Report on Form 10-K for the year ending December 31, 2005 as
pro forma footnote disclosure, as permitted under the transition
guidance provided by the Financial Accounting Standards Board under
SFAS No. 123R. Dan R. Lee, the Company's Chairman, President and
CEO, commented, "Because we have accelerated the vesting of these
options, we expect to avoid approximately $1.6 million in pre-tax
compensation expense related to these options over the next four
years. We do not expect that this action will result in a charge in
the current period. We believe this action is a prudent decision
and is in the best interest of the Company and our shareholders."
Actual Results Could Differ From Forward-Looking Statements: This
Press Release contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Such statements include, but are not limited
to, statements related to the Company's expectations regarding the
accounting treatment for stock options and the impact of
accelerating vesting of its stock options on the Company's
financial results in the current and future periods. Such
statements are subject to certain factors, risks and uncertainties
that may cause actual results, events and performance to differ
from those referred to in such statements. The Company does not
undertake to update its forward-looking statements to reflect
future events or circumstances. About Microtek Medical: Microtek
Medical is a leading manufacturer and supplier of innovative
product solutions for patient care, occupational safety and
management of infectious and hazardous waste for the healthcare
industry. Headquartered near Atlanta, Georgia, the Company offers
an extensive line of infection control, fluid control and safety
products, such as disposable equipment and patient drapes, which
are marketed to healthcare professionals through multiple channels,
including direct sales, original equipment manufacturers ("OEM's")
and private label arrangements. Microtek Medical's goal is to
provide healthcare professionals with innovative product solutions
that encompass a high-level of patient care and prevention of cross
infection in operating rooms and ambulatory surgical centers
worldwide. For further information, visit
http://www.microtekmed.com/. DATASOURCE: Microtek Medical Holdings,
Inc. CONTACT: Dan R. Lee, President & CEO, or Jerry Wilson,
CFO, or John Mills, Investor Relations, , all of Microtek Medical
Holdings, Inc., +1-800-476-5973 Web site:
http://www.microtekmed.com/
Copyright
Microtek Medical (NASDAQ:MTMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Microtek Medical (NASDAQ:MTMD)
Historical Stock Chart
From Jul 2023 to Jul 2024